“Shred-it Is The Right Prescription For Your HIPAA Headache.”


“Shred-it is theright prescriptionfor your HIPAAheadache.”Government legislation. Budget restrictions. Patient privacy. They don’t need to bea headache. Nationwide, companies like yours are turning to Shred-it for realisticsolutions to their immediate security concerns, and HIPAA compliance mandates.Shred-it is the world’s largest on-site documentdestruction and recycling company. Servicing moreU.S. healthcare organizations than any othercompany, Shred-it is the medical industry’s choicefor secure, cost-effective shredding.Alleviate your HIPAA headache.Call for a FREE Estimate.1 800 69-SHRED www.shredit.com

PE O PLERecognitionAppointmentsGail Carreau, MD, joinsNewport Women’s HealthCara Mathews, MD, wins YoungInvestigator AwardW W W. R I M E D . O R G RIMJ ARCHIVES F E B R U A RY W E B PA G ELiza Famador, MD; Camille Montes, MD,join Newport Hospital– Family Medicine physicians LIZAFAMADOR, MD , and CAMILLE MONTES,MD , have joined Portsmouth Family Medicine atNEWPORTNewport Hospital.Before coming to Newport Hospital, Dr. Famador, who is board certified in Family Medicine,worked for Comprehensive Community ActionProgram in Coventry. She is a graduate of theUniversity of the East Ramon Magsaysay Memorial Medical Center, Quezon City, Philippines,and completed a residency in Family Medicineat the University of Pittsburgh Medical CenterShadyside.Board certified in Family Medicine, Dr. Montescomes to Newport Hospital from Comprehensive Community Action Program in Cranston.Dr. Montes is a graduate of the University of Santo Tomas, Manila, Philippines, and completed aresidency in Family Medicine at the Universityof Pittsburgh Medical Center Shadyside. vFEBRUARY 2015L I F E S PA NN E W P O R T H O S P I TA LWOMEN & INFANTS– Newport Hospital announcedthat GAIL CARREAU, MD , has joined Newport Women’s Health as an obstetrician/gynecologist. She began seeing patients onJanuary 19.A graduate of George Washington University School of Medicine and board certified in obstetrics and gynecology, Dr.Carreau has extensive experience caring forwomen with high-risk pregnancies.She comes to Newport Hospital from Franciscan Women’s HealthAssociates in Tacoma, Washington. She completed her residency atthe Yale University-affiliated Bridgeport Hospital in Connecticut. Afellow of the American College of Obstetricians and Gynecologists,Dr. Carreau is also a member of the American Institute of Ultrasoundin Medicine. vNEWPORTLiza Famador, MDL I F E S PA N– The GynecologicOncology Group (GOG) Foundation recently announced thatCARA MATHEWS, MD , of theProgram in Women’s Oncologyat Women & Infants Hospitalof Rhode Island, earned its national Young Investigator Awardfor 2015.The award was given for Dr.Mathews’ research presentation, “Survival in advancedendometrial cancer: Does time to chemotherapyinitiation matter?” The research is sponsored byGenentech BioOncology.“Cara represents the latest generation of oncologist researchers, balancing time with her patientsin and the operating room with a desire to get tothe root of the enigma of gynecologic cancers,” saysCornelius “Skip” Granai III, MD, director of theProgram in Women’s Oncology. “She is gifted andcompassionate, and this is a great tribute to her tenacity as a researcher.”The goal of the Young Investigator program atGOG is to encourage physicians with not more thanfive years out of fellowship to participate in leading-edge research and become familiar with the inner workings of the organization. GOG is a nationalnon-profit organization dedicated to promoting excellence in the quality and integrity of clinical andbasic scientific research in the field of gynecologic oncology. It consists of gynecologic oncologists,medical oncologists, pathologists, radiation oncologists, nurses, statisticians, basic scientists, qualityof life experts, data managers, and administrativepersonnel.The award provides all data for the project fromprior trials done through GOG, financial supportfor statistical analysis, travel, and any other costs ofthe project. vPROVIDENCECamille Montes, MDRHODE ISLAND MEDICAL JOURNAL48

PE O PLEBharat Ramratnam, MD, named Medical Directorof Lifespan’s Clinical Research Center– Lifespan’s Clinical Research Center has named BHARATRAMRATNAM, MD , medical director.Dr, Ramratnam, who assumes the newrole immediately, will also continue tolead the Laboratory of Retrovirology forthe Lifespan/Tufts/Brown Center forAIDS Research and Rhode Island Hospital’s NIH-funded COBRE Center forCancer Research Development.“Since its launch last summer, theLifespan Clinical Research Center has played a critical role inhelping researchers manage important clinical trials in the departments of medicine, neurology, pediatrics and emergencymedicine. I’m pleased to have Dr. Ramratnam join our team andlead this important research resource,” said Peter Snyder, PhD,Lifespan senior vice president and chief research officer. “Dr.Ramratnam’s extensive research experience, which includes being the principal investigator for numerous NIH-funded projectsover the past 15 years, makes him well suited for this new role.”Dr. Ramratnam replaces the center’s first medical director,Catherine Gordon, MD, MSc, who is stepping down to devoteall of her time to her ongoing role as the director of the divisionof adolescent medicine at Hasbro Children’s Hospital.He is an associate professor of medicine at the Alpert MedicalSchool with appointments in the divisions of Infectious Diseasesand Hematology/Oncology. vPROVIDENCE– Lifespan has namedCARRIE BRIDGES FELIZ, MPH , tolead its Community Health Servicesteam.Bridges Feliz joins Lifespan withan extensive background in publichealth having served as the team lead for Health Disparitiesand Access to Care in the R.I. Department of Health. In thatrole, she supervised the offices of Minority Health, Women’sHealth, and Primary and Rural Health. She also served as apublic health prevention specialist for the Centers for Disease Control and Prevention (CDC), where she concentratedon Rhode Island refugee health; HIV, sexually transmitteddiseases, and tuberculosis prevention efforts; and infectiousdiseases.Bridges Feliz has earned numerous awards, including theWoman of Achievement Award from the YWCA of Rhode Island, the Women of Excellence Community Award from theWomen’s Center of Rhode Island, the President’s Award ofExcellence from the Urban League of Rhode Island and theCenters for Disease Control and Prevention Service Award.She has also served on several boards – Blue Cross and BlueShield of Rhode Island board of directors, the Young Voicesboard of directors, the CES, Inc. advisory board, and theboard of directors for the Central Rhode Island Area HealthEducation Center.Bridges Feliz earned her bachelor’s degree from Duke University and her master’s degree in public health from theBoston University School of Public Health. vDr. Herbert Brennan Named to International Medical PanelWARWICK – HERBERT J. “HUB” BRENNAN,DO , and Kent Hospital Medical Staffpresident, was appointed to the International Medical Panel of the Federation Internationale de Motcyclisme (FIM) at itsAnnual Congress on November 24, 2014in Jerez de la Frontera, Spain.The FIM, founded in 1904 is based inGeneva, Switzerland and is the worldgoverning body for motorcycle sport andrepresents the interests of motorcyclistsfrom 107 national motorcycle federations. Dr. Brennan is one of four U.S. representatives to the organization and thesole U.S. physician on the medical panel.The Rhode Island native is a lifelong and avid off-road motorcyclist andW W W. R I M E D . O R G RIMJ ARCHIVES advocate for the sport. Heis a member of the RhodeIsland Trials Club, New England Trials Association andthe American MotorcyclistAssociation. He holds an international medical licenseas a chief medical officer ofthe FIM.“I am at once humbledand extremely honored tohave been selected to the panel,” saidDr. Brennan. “While motorcycling herein the United States and in much of Europe is largely an endeavor of leisureand sport, many developing countriesemploy the motorcycle as a mainstay ofF E B R U A RY W E B PA G Ebasic family transportationand local economic infrastructure. I look forward toworking with our chairman,Dr. David McManus andmy colleagues on the panelto help make motorcyclingworldwide, as safe as it isenjoyable for all of us whoride on two wheels.”Dr. Brennan is a partnerin Brennan, Cronin and Peters InternalMedicine in East Greenwich, Rhode Island and serves on a number of boardsand committees focusing on healthcare governance and transformation. vFEBRUARY 2015K E N T H O S P I TA LL I F E S PA NPROVIDENCECarrie Bridges Feliz, MPH,to Lead Community HealthServices at LifespanRHODE ISLAND MEDICAL JOURNAL49L I F E S PA NAppointments

PE O PLEResearchDr. Olszewski Publishes Hodgkin’s Study in Journal of Clinical Oncology– ADAM OLSZEWSKI, MD , of The Cancer CenterCastillo - looked at 20,600 cases of early-stage Hodgkin lympho-at Memorial Hospital is the lead author of a study showing thatma reported between 2003 and 2011, treated with either CMThalf of Americans with early-state Hodgkin lymphoma do notor chemotherapy alone. They discovered that although nationalreceive therapy recommended by guidelines which may affectguidelines uniformly recommended CMT throughout the pasttheir survival rate. The study, conducted through Brown Univer-decade, only about half of patients received the full treatment,sity, was recently published in the Journal of Clinical Oncology.while the other half received chemotherapy without radiation.PAWTUCKETUntil now, there was no data about how patients with ear-Moreover, the proportion of cases treated with CMT decreasedly-stage Hodgkin lymphoma are treated in the U.S. and howsteadily over the years, especially among younger adults. Certaintreatment choices affect survival. Dr. Olszewski, an assistantgroups had a particularly low chance of receiving CMT. Theseprofessor of medicine at Alpert Medical School of Brown Uni-included younger women, older and sicker patients, Africanversity, led a team that studied these issues using informationAmericans, and patients without health insurance. Although 90from the National Cancer Data Base, which contains data on ap-percent of all patients survived more than five years after theirproximately 70 percent of newly diagnosed cancer cases in thediagnosis, those who received CMT appeared to have a signifi-U.S. and is a joint project of the Commission on Cancer of thecantly better survival rate compared with those who omittedAmerican College of Surgeons and the American Cancer Society.radiation. This advantage was present regardless of patients’The team – which included Dr. Rajesh Shrestha and Dr. Jorgeage, gender, race, or specific subtype of Hodgkin lymphoma.Dr. Olszewski noted, that choosing the best cancer treatmentis a complex process which is difficult to capture in large databases. The fact that the choice between CMT and chemotherapy alone is partly affected by patients’ race, health insurance orResearch core facilities are nowavailable to outside researchers.local treatment patterns underscores deficiencies of cancer caredelivery in the US. According to the US Census, about 30% ofAmericans younger than 30 years were uninsured in 2011, andthus at risk of receiving suboptimal treatment for early-stageHodgkin lymphoma.Omitting radiation therapy in half of the patients, he added,may indicate that doctors are concerned about its long-term toxicity for their patients, even though radiation techniques in the21st century are more advanced. The team of scientists said future clinical trials in Hodgkin lymphoma are needed and shouldfocus on minimizing toxicities without compromising survival in order to meet the concerns of patients and physicians. v6 facilities featuring state-of-the-art research equipment: Flow Cytometry and Cell Sorting Imaging Molecular GMP Cell Production Tissue Bank Animal ServicesTo learn more about the research core facilities and feeschedule at Roger William Medical Center, contactJohn W. Morgan, Ph.D., Core Facilities Manager,at 741-3115 or jmorgan@chartercare.org.Or visit www.rwmc.org/core-research-facilities/W W W. R I M E D . O R G RIMJ ARCHIVES F E B R U A RY W E B PA G EFEBRUARY 2015RHODE ISLAND MEDICAL JOURNAL50

PE O PLEObituariesREYNALDO S. LINSAO, MD , 74, of John-ABRAHAM HORVITZ, MD , 103, of Providence,passed away peacefully on January 27, 2015 at hishome at Laurelmead. The first child of Jacob and Fanny Horvitzof Providence, he was a graduate of Classical High School andBrown University. He decided to become a doctor as a teenagerand earned his MD at Columbia Medical School in 1936. Whenhe went to Washington University in St. Louis to do his residency he was joined by his new wife, the former Eleanor Feldman.He was working at Harlem Hospital in New York when PearlHarbor was attacked and although exempted from the draft because he was a doctor, he felt that it was obligation to enlist. Bythe end of 1942, now a lieutenant in the Third Army SurgicalCorps, he was on board a transport ship headed for England. (Hewas subsequently promoted to captain.) On D 1 June 7, 1944 onUtah Beach in Normandy, he was in a surgical tent, operatingon wounded American and German soldiers. Months later, hewould come under fire in the Battle of the Bulge but nothingcould have prepared him for the horror that awaited him whenhe witnessed the liberation of a concentration camp, a searingexperience that almost certainly strengthened his identity as aJew and made him an ardent supporter of Israel. What he remembered most especially was an ambush of U.S. battleshipsby U-boats in the English Channel during a practice run for theD-Day invasion. A ship ahead of his and another just behind itwere blown out of the water with appalling loss of life. His ship,however, went untouched. God, he believed, had saved him forsome purpose, a belief that thousands of his patien

The Rhode Island native is a life-long and avid off-road motorcyclist and advocate for the sport. He is a member of the Rhode Island Trials Club, New En-gland Trials Association and the American Motorcyclist Association. He holds an in-ternational medical license as a chief medical officer of the FIM. “I am at once humbled and extremely honored to